Biomarkers in Prediction of AMI

Not Applicable

Recruiting

• Conditions: Acute Mesenteric Ischemia

• Registration Number: NCT06212921
• Lead Sponsor: University of Tartu

Brief Summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-01-04
• Study First Submitted QC: 2024-01-15
• Study First Posted: 2024-01-19
• Study Start: 2024-10-14
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-27
• Last Update Posted: 2024-12-03
• Primary Completion: 2025-09
• Study Completion: 2025-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Age 18 years or older
• Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion Criteria

• Age <18 years
• Consent declined by patient or next of kin (delayed consent)
• Chronic mesenteric ischaemia without an acute event
• Immediate decision for withdrawal of further diagnostics and active treatment
• Referral from another hospital with already established diagnosis of AMI
• AMI diagnosed at surgery without previously having been considered

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Rate of correctly predicted cases of acute mesenteric ischaemia	10 months	Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

Trial Locations

Locations (2)

Tartu University Hospital; 🇪🇪 Tartu, Estonia

Lucerne Cantonal Hospital; 🇨🇭 Luzern, Switzerland